RB1 and breast cancer: Furthermore, de novo oncogenesis of BC was modeled through CRISPR-Cas9-mediated targeted knockout of frequently mutated tumor suppressor genes (P53, PTEN, RB1, NF1) in organoids derived from human breast epithelial cells [213].